LOWER RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR: A REACH-B ANALYSIS OF THE ENUMERATE STUDY

被引:0
|
作者
Ahn, J. [1 ]
Nguyen, M. [2 ]
Lee, H. [3 ]
Lim, J. [4 ]
Pan, C. [5 ]
Te, H. [6 ]
Tran, T. [7 ]
Trinh, H. N. [8 ]
Lau, D. [9 ]
Chu, D. [10 ]
Min, A. [11 ]
Leduc, T. -S. [12 ]
Pillai, A. [13 ]
Bae, H. [14 ]
Do, S. [15 ]
Mannalithara, A. [2 ]
Lok, A. S. [16 ]
Kim, W. R. [2 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Stanford Univ, Stanford, CA 94305 USA
[3] Tufts Univ, Boston, MA 02111 USA
[4] Yale Univ, New Haven, CT USA
[5] NYU Langone, New York, NY USA
[6] Univ Chicago, Chicago, IL 60637 USA
[7] Cedars Sinai, Los Angeles, CA USA
[8] San Jose Gastroenterol, San Jose, CA USA
[9] Beth Israel Deaconess Med Ctr, Boston, MA USA
[10] Albert Einstein Coll Med, New York, NY USA
[11] Mt Sinai Beth Israel, New York, NY USA
[12] Leduc Med Grp Inc, Fountain Valley, CA USA
[13] Emory Univ, Atlanta, GA 30322 USA
[14] St Vincents Med Ctr, Los Angeles, CA USA
[15] Digest Hlth Associates Texas, Plano, TX USA
[16] Univ Michigan, Ann Arbor, MI 48109 USA
关键词
D O I
10.1016/S0168-8278(15)30851-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P0646
引用
收藏
页码:S562 / S562
页数:1
相关论文
共 50 条
  • [31] The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus
    Kramer, Jennifer R.
    Richardson, Peter A.
    Kim, Hyunseok
    Hsu, Yao-Chun
    Kanwal, Fasiha
    El-Serag, Hashem B.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 1111 - 1113
  • [32] PERFORMANCE OF HEPATOCELLULAR CARCINOMA RISK SCORES IN CHRONIC HEPATITIS B PATIENTS RECEIVING ENTECAVIR TREATMENT
    Wong, V. W. -S.
    Wong, G. L. -H.
    Chan, H. -Y.
    Tse, C. -H.
    Chan, H. L. -Y.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S19 - S19
  • [33] Entecavir treatment significantly reduces the risk of hepatocellular carcinoma recurrence in patients with chronic hepatitis b
    Lee, Donghyeon
    Lee, Jeong-Hoon
    Cho, Yuri
    Lee, Yun Bin
    Kwon, Jung Hee
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    Kim, Chung Yong
    HEPATOLOGY, 2012, 56 : 371A - 371A
  • [34] Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir
    Hsu, Yao-Chun
    Ho, Hsiu-J.
    Lee, Teng-Yu
    Huang, Yen-Tsung
    Wu, Ming-Shiang
    Lin, Jaw-Town
    Wu, Chun-Ying
    El-Serag, Hashem B.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 543 - 551
  • [35] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR
    Yim, Hyung Joon
    Kang, Seong Hee
    Jung, Young Kul
    Ahn, Sang Hoon
    Kim, Won
    Yang, Jin Mo
    Jang, Jae Young
    Cho, Yong Kyun
    Kim, Yoon Jun
    Kim, Dong Joon
    Kweon, Young-Oh
    Hong, Gun Young
    Sohn, Joo Hyun
    Lee, Jin-Woo
    Park, Sung Jae
    Young, Yim Sun
    Shin, Seung Kak
    Kim, Ji Hoon
    Seo, Yeon Seok
    Park, Jin Kyung
    Um, Soonho
    HEPATOLOGY, 2023, 78 : S1828 - S1829
  • [36] No difference in hepatocellular carcinoma risk in chronic hepatitis B patients treated with tenofovir vs entecavir: evidence from an updated meta-analysis
    Yuan, Jie
    Peng, Yang
    Hao, Fa-Bao
    Wang, Ya-Qin
    Wang, Chun-Rui
    Zhong, Guo-Chao
    AGING-US, 2021, 13 (05): : 7147 - 7165
  • [37] RETRACTED: Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study (Retracted Article)
    Choi, Jonggi
    Kim, Hyo Jeong
    Lee, Jayoun
    Cho, Songhee
    Ko, Min Jung
    Lim, Young-Suk
    JAMA ONCOLOGY, 2019, 5 (01) : 30 - 36
  • [38] Risk of Hepatocellular Carcinoma Among Treated Patients With Chronic Hepatitis B vs Chronic Hepatitis C
    Kim, Gi-Ae
    Han, Seungbong
    An, Jihyun
    Lim, Young-Suk
    HEPATOLOGY, 2014, 60 : 1092A - 1092A
  • [39] TENOFOVIR COMPARED TO ENTECAVIR ON RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Choi, Won-Mook
    Choi, Jonggi
    Lim, Young-Suk
    HEPATOLOGY, 2019, 70 : 307A - 307A
  • [40] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1083 - 1092